Search

everythinglearnresearchcommunity

for

Search:↓

Botulinum toxin type A helps treat hair loss by stopping cell death in hair follicles through a process involving certain non-coding RNAs and a protein called Bax.

The man has Temporal Triangular Alopecia, a stable, non-scarring hair loss condition best treated with hair transplantation.

AI can improve early diagnosis and treatment of diabetic foot complications but requires addressing training and ethical challenges.

The research suggests that Tourette syndrome is linked to both brain signaling and immune system pathways.

High-throughput LC-MS screening is effective for finding new autotaxin inhibitors for asthma treatment.

Temporal triangular alopecia is a non-scarring hair loss in children, often linked to other health conditions.

Ritlecitinib effectively promotes hair regrowth in severe and very severe alopecia areata.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

The AI model DIET-AI effectively diagnoses skin diseases as well as doctors.

Tofacitinib is effective for treating alopecia areata, and starting treatment early may improve results.

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

JAK inhibitors like tofacitinib may effectively treat alopecia in children without major side effects.

CS12192 effectively treats alopecia areata with better safety than current options.

The MBTPS2 gene variant c.970+5G>A is a common mutation causing IFAP syndrome.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

Oral tofacitinib can treat both psoriasis and alopecia universalis by normalizing inflammatory pathways.

Baricitinib helps regrow hair and improves quality of life and mental health in severe alopecia areata patients.

TAF4 is important for skin cell growth and helps prevent skin cancer in mice.

Baricitinib effectively promotes hair regrowth in both scalp and nonscalp areas for alopecia areata universalis patients.

Oral baricitinib is effective and safe for treating alopecia areata.

Patients and doctors often agree on the severity of eyebrow and eyelash hair loss in severe alopecia areata.

Baricitinib helped a woman with severe hair loss regrow almost all her hair without side effects.

Reducing the dose of Baricitinib to 2mg led to a loss of hair regrowth benefits in nearly half of the patients by Week-104.

Temporary facial blanching can occur after Botulinum toxin injections, but it resolves without discomfort.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

Tiger tail banding and hair abnormalities are reliable indicators for diagnosing trichothiodystrophy.

The formulated gel is a promising treatment for alopecia areata.

Baricitinib works better than methotrexate for severe alopecia areata.